Status:
TERMINATED
Remineralization Agents for the Treatment of White Spot Lesions
Lead Sponsor:
Ministry of Health, Bahrain
Conditions:
White Spot Lesion of Tooth
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Clinically, formation of white spots can occur as early as 4 weeks into orthodontic treatment and very common in high caries risk individuals. When left untreated, the calcium loss continues, the enam...
Detailed Description
White spot lesion (WSL) is the earliest sign of demineralization of the enamel and a common problem caused because of plaque accumulation and poor oral hygiene. These WSLs are of great concern in youn...
Eligibility Criteria
Inclusion
- Adult patients attending the dental clinic for treatment of white spot lesions on their teeth
- using fluoride toothpaste once or twice daily for brushing
- does not use any other form of fluoride
- history of recent fixed orthodontic treatment
- presenting with white spot lesions on minimum of three anterior or posterior teeth on the labial surfaces
- provide written informed consent
Exclusion
- Patients who do not fit into the above mentioned inclusion criteria.
- Patients who are allergic to milk or any other milk products will be excluded from the study. Milk protein allergy and lactose intolerance tests will be performed on participants belonging to active comparators Tooth Mousse and MI paste which contain casein phosphoprotein before enrolling them in the trial.
- Patients who are vegan and do not use or consume any animal products
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04827966
Start Date
September 1 2022
End Date
December 1 2022
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Halet bu maher health center
Al Muharraq, Bahrain